ERK1/2 Signaling Pathway in the Release of VEGF from Müller Cells in Diabetes
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
PURPOSE: Diabetic retinopathy (DR) is one of the most serious complications of diabetes and has become a major blinding eye disease, but its treatment remains unsatisfactory. The ERK1/2 signaling pathway has been shown to participate in regulating secretion of VEGF in DR from our previous studies. The role of VEGF in the development of DR provides a target for treatment. Our present research focuses on Müller cells, a major source of VEGF secretion, to investigate the role of ERK1/2 signaling pathway on regulation of VEGF release in diabetes. METHODS: Immunofluorescence was used to observe the ERK1/2 phosphorylation activity on early diabetic rat retinal Müller cells. Müller cells were stimulated by high glucose in vitro. Western blot and immunohistochemistry were used to determine ERK1/2 signaling pathway expression and phosphorylation. AP-1 DNA binding activity status was monitored by electrophoretic mobility shift assay (EMSA). ELISA and PCR monitored VEGF secretion. Inhibition of ERK1/2 phosphorylation with U0126 was observed for changes in VEGF secretion. RESULTS: Phos-ERK1/2 was expressed on Müller cells early in diabetes. In vitro high glucose stimulation of Müller cells increased VEGF secretion with a peak at 24 hours. An ERK1/2 specific inhibitor, U0126, stopped the phosphorylation of ERK1/2, lowered AP-1 DNA binding activity, and reduced Müller cells secretion of VEGF under high glucose conditions. CONCLUSIONS: ERK1/2 signaling pathway has some role in regulating Müller cells secretion of VEGF in DR. Targeting the ERK1/2 signaling pathway in Müller cells through intervention of the upstream signaling pathway or nuclear transcription factors of VEGF secretion could be a type of anti-VEGF treatment for DR.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and that it specifically regulates VEGF secretion by MG cells [ 81 ].”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [81]
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Karin, M., Liu, Z.-G., & Zandi, E. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80068-3 · Cited by 2,893
The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases
Karin, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16483 · Cited by 2,431
Signal Transduction through MAP Kinase Cascades
(1998) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60765-4 · Cited by 1,759
Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., & Abraham, J. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99049-6 · Cited by 1,476
Pierce, E. A., Avery, R. L., Foley, E. D., Aiello, L. P., & Smith, L. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.905 · Cited by 1,027
Stone, J., Itin, A., Alon, T., Pe'er, J., Gnessin, H., Chan-Ling, T., & Keshet, E. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-07-04738.1995 · Cited by 1,006
The Müller cell: a functional element of the retina
Newman, E., & Reichenbach, A. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10040-0 · Cited by 788
Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy.
Mizutani, M., Kern, T. S., & Lorenzi, M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118746 · Cited by 706
Activation of ternary complex factor Elk-1 by MAP kinases.
Janknecht, R., Ernst, W. H., Pingoud, V., & Nordheim, A. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06204.x · Cited by 560
Cited by
Impact of the opioid system on the reproductive axis
Böttcher, B., Seeber, B., Leyendecker, G., & Wildt, L. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.06.009 · Cited by 115
Small-molecule compounds target paraptosis to improve cancer therapy
Wang, Y., Wen, X., Zhang, N., Wang, L., Hao, D., Jiang, X. L., & He, G. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109203 · Cited by 91
Long, L., Li, Y., Yu, S., Li, X., Hu, Y., Long, T., Wang, L., Li, W., Ye, X., Ke, Z., et al. (2019) · Journal of Diabetes Research · doi:10.1155/2019/4875421 · Cited by 73
Self-citationLi, T., Hu, J., Du, S., Chen, Y., Wang, S., & Wu, Q. E. (2014) · PubMed Central · Cited by 73
Fan, Y., Liu, K., Wang, Q., Ruan, Y., Ye, W., & Zhang, Y. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.05.004 · Cited by 70
Metadata
- Authors
- Ye, X., Ren, H., Zhang, M., Sun, Z., Jiang, A. C., & Xu, G.
- Affiliations
- Shanghai Medical College of Fudan University (CN)
- Corresponding author
- Ye, Xiaofeng
- Ren, Hui
- Zhang, Meng
- Sun, Zhongcui
- Jiang, Alice C.
- Xu, Gezhi
- Venue
- Investigative Opthalmology & Visual Science
- Published
- 2012-06-08
- Volume
- 53
- Issue
- 7
- Pages
- 3481
- ISSN
- 0146-0404 (ISSN-L)
- 1552-5783
- OpenAlex
- W1963818413
- Cited by
- 44
- References
- 43
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 4 · 2023: 1 · 2022: 2 · 2021: 3 · 2020: 3 · 2019: 5 · 2018: 3 · 2017: 2 · 2016: 5 · 2015: 4 · 2014: 3 · 2013: 2 · 2012: 1
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Investigative Ophthalmology & Visual Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Keywords
- ERK signaling, VEGF secretion, Müller cells, diabetic retinopathy, high glucose, AP-1 DNA binding, U0126, ERK1/2 phosphorylation, anti-VEGF therapy
- MeSH terms
- Animals, Butadienes, Diabetes Mellitus, Experimental, Diabetic Retinopathy, Enzyme Inhibitors, Enzyme-Linked Immunosorbent Assay, Glucose, Male, Neuroglia, Nitriles, Phosphorylation, Blotting, Western, Rats, Sprague-Dawley, Transcription Factor AP-1, Fluorescent Antibody Technique, Indirect, Mitogen-Activated Protein Kinase 1, MAP Kinase Signaling System, Electrophoretic Mobility Shift Assay, Vascular Endothelial Growth Factor A, Mitogen-Activated Protein Kinase 3, Rats, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.